GlycanAge Champion 2026
Recognized as the World’s Only GlycanAge Champion
On June 20, 2026, Takashi Nishihira, CEO of ExoEarth Corporation, was honored by GlycanAge as the recipient of the GlycanAge Champion 2026 (Immune Health Champion) award at the international conference Inflammaging in Clinical Practice 2026, held in Dubrovnik, Croatia.
Mr. Nishihira was the only individual recognized as a GlycanAge Champion in 2026 and was introduced as the sole recipient of this global distinction.
Assessment Results
The award was based on the following evaluation results derived from the GlycanAge international database.
| Chronological Age | 66 |
|---|---|
| Biological Age (GlycanAge) | 20 |
| Age Difference | -46 Years |
| Percentile Rank | Top 1% |
What is GlycanAge?
GlycanAge is a biological age assessment platform that analyzes Immunoglobulin G (IgG) glycosylation patterns in blood to evaluate immune status and chronic inflammation, often referred to as inflammaging.
The scientific foundation of GlycanAge originates from large-scale European studies involving more than 5,000 participants, demonstrating that IgG glycans serve as powerful biomarkers reflecting biological aging.
Further twin studies have shown that GlycanAge is influenced not only by genetics but also by lifestyle and environmental factors. As a result, GlycanAge is now used internationally as a measurable and potentially improvable indicator of health status.
For more information about glycan science, please visit our Glycan Science page.
Champion’s Message
I am deeply honored to receive this recognition.
At the same time, I believe this award does not belong to me alone. It reflects the collective efforts of researchers, healthcare professionals, partner organizations, and everyone who has supported our journey over the years.
The world is entering an era of unprecedented population aging.
Drawing upon the knowledge, experience, and practices cultivated in Japan, we hope to contribute new possibilities for extending healthy longevity around the world.
This award is not the destination.
Rather, it represents a new starting point for sharing a next-generation longevity model from Japan to the global community.
We believe the future is not only about measuring healthy longevity, but also about cultivating it.
By connecting science, data, AI, and everyday practice, we aim to contribute to longer and healthier lives for people everywhere.
Takashi Nishihira
CEO, ExoEarth Corporation
ExoEarth’s Challenge
We do not view healthy longevity simply as living longer.
The more important question is not how long we live, but how long we can remain healthy, active, and capable of living life on our own terms.
Through continuous observation, data-driven understanding, and personalized optimization, ExoEarth seeks to create a future where individuals can sustain their wellbeing throughout life.
This recognition represents one practical example of that ongoing mission.